Histone deacetylase inhibition induces apoptosis and autophagy in human neuroblastoma cells

Cancer Letters

Volumn 318, Issue 1, 2012, Pages 42-52

  Francisco, Roser ^a   Pérez Perarnau, Alba ^a   Cortés, Constanza ^a   Gil, Joan ^a   Tauler, Albert ^a   Ambrosio, Santiago ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Apoptosis; Autophagy; HDACi; Neuroblastoma; Trichostatin A

Indexed keywords

CASPASE; HISTONE DEACETYLASE; TRICHOSTATIN A;

APOPTOSIS; ARTICLE; AUTOPHAGY; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INHIBITION; G2 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LONG TERM EXPOSURE; NEUROBLASTOMA; NEUROBLASTOMA CELL; ONCOGENE C MYB; PHENOTYPIC VARIATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ACETYLATION; APOPTOSIS; AUTOPHAGY; BLOTTING, WESTERN; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HUMANS; HYDROXAMIC ACIDS; NEUROBLASTOMA; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84857140530     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.11.036     Document Type: Article

References (47)

1. Kristensen L.S., Nielsen H.M., Hansen L.L. Epigenetics and cancer treatment. Eur. J. Pharmacol. 2009, 625:131-142.
2. Marks P.A., Xu W.S. Histone deacetylase inhibitors: potential in cancer therapy. J. Cell. Biochem. 2009, 107:600-608.
3. Furchert S.E., Lanvers-Kaminsky C., Juurgens H., Jung M., Loidl A., Fruhwald M.C. Inhibitors of histone deacetylases as potential therapeutic tools for high-risk embryonal tumors of the nervous system of childhood. Int. J. Cancer 2007, 120:1787-1794.
4. Ungerstedt J.S., Sowa Y., Xu W.S., Shao Y., Dokmanovic M., Perez G., Ngo L., Holmgren A., Jiang X., Marks P.A. Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors. Proc. Natl. Acad. Sci. USA 2005, 102:673-678.
5. Bolden J.E., Peart M.J., Johnstone R.W. Anticancer activities of histone deacetylase inhibitors. Nat. Rev. Drug Discov. 2006, 5:769-784.
6. Maris J.M. Recent advances in neuroblastoma. N. Engl. J. Med. 2010, 362:2202-2211.
7. Jogi A., Ora I., Nilsson H., Poellinger L., Axelson H., Pahlman S. Hypoxia-induced dedifferentiation in neuroblastoma cells. Cancer Lett. 2003, 197:145-150.
8. Witt O., Deubzer H.E., Lodrini M., Milde T., Oehme I. Targeting histone deacetylases in neuroblastoma. Curr. Pharm. Des. 2009, 15:436-447.
9. Coffey D.C., Kutko M.C., Glick R.D., Swendeman S.L., Butler L., Rifkind R., Marks P.A., Richon V.M., LaQuaglia M.P. Histone deacetylase inhibitors and retinoic acids inhibit growth of human neuroblastoma in vitro. Med. Pediatr. Oncol. 2000, 35:577-581.
10. Subramanian C., Opipari A.W., Bian X., Castle V.P., Kwok R.P. Ku70 acetylation mediates neuroblastoma cell death induced by histone deacetylase inhibitors. Proc. Natl. Acad. Sci. USA 2005, 102:4842-4847.
11. Eisenberg-Lerner A., Bialik S., Simon H.U., Kimchi A. Life death partners: apoptosis autophagy and the cross-talk between them. Cell Death Differ. 2009, 16:966-975.
12. Gozuacik D., Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene 2004, 23:2891-2906.
13. Levine B. Autophagy and cancer. Nature 2007, 446:745-747.
14. Gimenez-Xavier P., Francisco R., Santidrian A.F., Gil J., Ambrosio S. Effects of dopamine on LC3-II activation as a marker of autophagy in a neuroblastoma cell model. Neurotoxicology 2009, 30:658-665.
15. Gomez-Santos C., Ferrer I., Santidrian A.F., Barrachina M., Gil J., Ambrosio S. Dopamine induces autophagic cell death and alpha-synuclein increase in human neuroblastoma SH-SY5Y cells. J. Neurosci. Res. 2003, 73:341-350.
16. Walton J.D., Kattan D.R., Thomas S.K., Spengler B.A., Guo H.F., Biedler J.L., Cheung N.K., Ross R.A. Characteristics of stem cells from human neuroblastoma cell lines and in tumors. Neoplasia 2004, 6:838-845.
17. Bian X., Opipari A.W., Ratanaproeksa A.B., Boitano A.E., Lucas P.C., Castle V.P. Constitutively active NFkappa B is required for the survival of S-type neuroblastoma. J. Biol. Chem. 2002, 277:42144-42150.
18. Miller S., Tavshanjian B., Oleksy A., Perisic O., Houseman B.T., Shokat K.M., Williams R.L. Shaping development of autophagy inhibitors with the structure of the lipid kinase Vps34. Science 2010, 327:1638-1642.
19. Castaño E., Bartrons R., Gil J. Inhibition of cyclooxygenase-2 decreases DNA synthesis induced by platelet-derived growth factor in swiss 3T3 fibroblasts. J. Pharmacol. Exp. Ther. 2000, 293:509-513.
20. Coll-Mulet L., Iglesias-Serret D., Santidrian A.F., Cosialls A.M., de Frias M., Castaño E., Campas C., Barragan M., de Sevilla A.F., Domingo A., Vassilev L.T., Pons G., Gil J. MDM2 antagonists activate p53 and synergize with genotoxic drugs in B-cell chronic lymphocytic leukemia cells. Blood 2006, 107:4109-4114.
21. Johnsen J.I., Kogner P., Albihn A., Henriksson M.A. Embryonal neural tumours and cell death. Apoptosis 2009, 14:424-438.
22. Condorelli F., Gnemmi I., Vallario A., Genazzani A.A., Canonico P.L. Inhibitors of histone deacetylase (HDAC) restore the p53 pathway in neuroblastoma cells. Br. J. Pharmacol. 2008, 153:657-668.
23. Rocchi P., Tonelli R., Camerin C., Purgato S., Fronza R., Bianucci F., Guerra F., Pession A., Ferreri A.M. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid tributyrin and sodium butyrate) in neuroblastoma cells. Oncol. Rep. 2005, 13:1139-1144.
24. Oh M., Choi I.K., Kwon H.J. Inhibition of histone deacetylase1 induces autophagy. Biochem. Biophys. Res. Commun. 2008, 369:1179-1183.
25. Watanabe M., Adachi S., Matsubara H., Imai T., Yui Y., Mizushima Y., Hiraumi Y., Watanabe K., Kamitsuji Y., Toyokuni S.Y., Hosoi H., Sugimoto T., Toguchida J., Nakahata T. Induction of autophagy in malignant rhabdoid tumor cells by the histone deacetylase inhibitor FK228 through AIF translocation. Int. J. Cancer 2009, 124:55-67.
26. Liu Y.L., Yang P.M., Shun C.T., Wu M.S., Weng J.R., Chen C.C. Autophagy potentiates the anti-cancer effects of the histone deacetylase inhibitors in hepatocellular carcinoma. Autophagy 2010, 6:1057-1065.
27. Chen M.Y., Liao W.S., Lu Z., Bornmann W.G., Hennessey V., Washington M.N., Rosner G-L., Yu Y., Ahmed A.A., Bast R.C. Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy. Cancer 2011, 10.1002/cncr.26073.
28. Lu Z., Luo R.Z., Peng H., Huang M., Nishmoto A., Hunt K.K., Helin K., Liao W.S.L., Yu Y. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer. Oncogene 2006, 25:230-239.
29. Zhao Y., Tan J., Zhuang L., Jiang X., Liu E.T., Yu Q. Inhibitors of histone deacetylases target the rb-E2F1 pathway for apoptosis induction through activation of proapoptotic protein bim. Proc. Natl. Acad. Sci. USA 2005, 102:16090-16095.
30. Strieder V., Lutz W. E2F proteins regulate MYCN expression in neuroblastomas. J. Biol. Chem. 2003, 278:2983-2989.
31. Kim M.K., Carroll W.L. Autoregulation of the N-myc gene is operative in neuroblastoma and involves histone deacetylase 2. Cancer 2004, 101:2106-2115.
32. Muhlethaler-Mottet A., Meier R., Flahaut M., Bourloud K.B., Nardou K., Joseph J.M., Gross N. Complex molecular mechanisms cooperate to mediate histone deacetylase inhibitors anti-tumour activity in neuroblastoma cells. Mol. Cancer 2008, 7:55.
33. Francisco R., Perez-Tomas R., Gimenez-Bonafe P., Soto-Cerrato V., Gimenez-Xavier P., Ambrosio S. Mechanisms of prodigiosin cytotoxicity in human neuroblastoma cell lines. Eur. J. Pharmacol. 2007, 572:111-119.
34. Wang Z.M., Hu J., Zhou D., Xu Z.Y., Panasci L.C., Chen Z.P. Trichostatin A inhibits proliferation and induces expression of p21WAF and p27 in human brain tumor cell lines. Ai Zheng 2002, 21:1100-1105.
35. Boya P., Gonzalez-Polo R.A., Casares N., Perfettini J.L., Dessen P., Larochette N., Metivier D., Meley D., Souquere S., Yoshimori T., Pierron G., Codogno P., Kroemer G. Inhibition of macroautophagy triggers apoptosis. Mol. Cell. Biol. 2005, 25:1025-1040.
36. Platini F., Perez-Tomas R., Ambrosio S., Tessitore L. Understanding autophagy in cell death control. Curr. Pharm. Des. 2010, 16:101-113.
37. Eisenberg-Lerner A., Kimchi A. The paradox of autophagy and its implication in cancer etiology and therapy. Apoptosis 2009, 14:376-391.
38. Wu Y.T., Tan H.L., Shui G., Bauvy C., Huang Q., Wenk M.R., Ong C.N., Codogno P., Shen H.M. Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase. J. Biol. Chem. 2010, 285:10850-10861.
39. Passonneau J.V., Crites S.K. Regulation of glycogen metabolism in astrocytoma and neuroblastoma cells in culture. J. Biol. Chem. 1976, 251:2015-2022.
40. Fangusaro J.R., Caldas H., Jiang Y., Altura R.A. Survivn: an inhibitor of apoptosis in pediatric cancer. Pediatr. Blood Cancer 2006, 47:4-13.
41. Roca H., Varsos Z., Pienta K.J. CCL2 protects prostate cancer PC3 cells from autophagic death via phosphatidylinositol 3-kinase/AKT-dependent survivin up-regulation. J. Biol. Chem. 2008, 283:25057-25073.
42. Wang Q., Chen Z., Diao X., Huang S. Induction of autophagy-dependent apoptosis by the survivin suppressant YM155 in prostate cancer cells. Cancer Lett. 2011, 302:29-36.
43. Walton J.D., Kattan D.R., Thomas S.K., Spengler B.A., Guo H-F., Biedler J.L., Cheung N-K.V., Ross R.A. Characteristics of stem cells from human neuroblastoma cell lines and in tumors. Neoplasia 2004, 6:838-845.
44. Nishida Y., Adati N., Ozawa R., Maeda A., Sakaki Y., Takeda T. Identification and classification of genes regulated by phosphatidylinositol 3-kinase- and TRKB-mediated signalling pathways during neuronal differentiation in two subtypes of the human neuroblastoma cell line SH-SY5Y. BMC Res. Notes 2008, 1:95. 10.1186/1756-0500-1-95.
45. Vanhaecke T., Henkens T., Kass G.E., Rogiers V. Effect of the histone deacetylase inhibitor trichostatin A on spontaneous apoptosis in various types of adult rat hepatocyte cultures. Biochem. Pharmacol. 2004, 68:753-760.
46. Gross A. BID as a double agent in cell life and death. Cell Cycle 2006, 5:582-584.
47. Kondo Y., Kanzawa T., Sawaya R., Kondo S. The role of autophagy in cancer development and response to therapy. Nat. Rev. Cancer 2005, 5:726-734.